Ameerpet, India

Aurobindo Pharma Limited


USPTO Granted Patents = 53

% Expired Patents = 77.4


Trademarks = 11

Forward Citations = 67

Loading Chart...
Loading Chart...

135 inventors (with patents filed for the assignee):

goldMedal Sivakumaran Meenakshisunderam (40 out of 41 patents)

silverMedal Ramesh Dandala (17 out of 26 patents)

bronzeMedal Meenakshisunderam Sivakumaran (9 out of 9 patents)

4.  Sukumar Nandi (8 out of 8 patents)

5.  Sambhu Prasad Sarma Mallela (6 out of 6 patents)

6.  Vijay Kumar Handa (5 out of 10 patents)

7.  Shankar Reddy Budidet (4 out of 4 patents)

8.  Jagan Mohan Reddy Sanapureddy (3 out of 4 patents)

9.  Subba Reddy Danda (3 out of 3 patents)

10.  Gangadhara Bhima Shankar Nangi (3 out of 3 patents)

11.  Rani Ananta (3 out of 3 patents)

12.  Arun Kumar Gupta (3 out of 3 patents)

13.  Divvela Venkata Naga Srinivasa Rao (3 out of 3 patents)

14.  Saravanan Kannusamy (3 out of 3 patents)

15.  Nagaprasad Vishnubhotla (2 out of 4 patents)


Core Competencies:
Eluxadoline
Trametinib
Naloxegol
Deutetrabenazine
Canagliflozin
Pimavanserin
Lifitegrast
Cariprazine
Ivermectin
Valsartan
Rosuvastatin
Escitalopram

53 patents:

Aurobindo Pharma Limited is a prominent player in the pharmaceutical industry, headquartered in Ameerpet, India. The company specializes in the development and manufacturing of a diverse range of pharmaceutical compositions, focusing on innovative therapies. Its core technology topics include notable compounds such as Eluxadoline, Trametinib, and Naloxegol, among others. Aurobindo's commitment to research and development drives its efforts in creating effective solutions across various therapeutic areas, contributing significantly to global healthcare.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Aurobindo Pharma Limited
53 Patents

#1 in Ameerpet

#37 in India

#13,309 in the World

Ameerpet, IN
Ameerpet, India
Forward Citations = 67

135 inventors:

Please report any incorrect information to [email protected]
Loading…